These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27329)

  • 1. Pharmacologic antagonists to gastric acid secretion.
    Dinoso VP
    Compr Ther; 1978 Jul; 4(7):40-3. PubMed ID: 27329
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacological inhibition of gastric secretion and treatment of peptic ulcer].
    Konturek SJ
    Rev Esp Enferm Apar Dig; 1978 Apr; 53(1):65-82. PubMed ID: 26940
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacologic control of gastric acid secretion in peptic ulcer.
    Konturek SJ
    Mt Sinai J Med; 1983; 50(6):457-67. PubMed ID: 6141524
    [No Abstract]   [Full Text] [Related]  

  • 4. Newer antisecretory agents for peptic ulcer.
    Somerville KW; Langman MJ
    Drugs; 1983 Mar; 25(3):315-30. PubMed ID: 6133734
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacologic treatment of ulcers].
    Honorato Pérez J; Azanza Perea JR; Cuena Boy R
    Rev Med Univ Navarra; 1984 Jun; 28(2):53-8. PubMed ID: 6149611
    [No Abstract]   [Full Text] [Related]  

  • 6. [Gastric acid secretion inhibitors: H2 receptor antagonists (H2RA), proton pump inhibitors (PPI) or acid pump antagonists (APA)].
    Mazure PA
    Acta Gastroenterol Latinoam; 1996; 26(4):263-5. PubMed ID: 9335935
    [No Abstract]   [Full Text] [Related]  

  • 7. [Gastric secretion blockaders in peptic ulcer].
    Arutionian VM; Minasian GA
    Sov Med; 1989; (7):45-8. PubMed ID: 2572058
    [No Abstract]   [Full Text] [Related]  

  • 8. Current concepts in clinical therapeutics: peptic ulcer disease.
    Siepler JK; Mahakian K; Trudeau WT
    Clin Pharm; 1986 Feb; 5(2):128-42. PubMed ID: 2869852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic options for the control of peptic ulcer disease.
    Levine JB
    Adv Intern Med; 1984; 30():425-47. PubMed ID: 6152108
    [No Abstract]   [Full Text] [Related]  

  • 10. Drugs for treatment of peptic ulcers.
    Dajani EZ; Trotman BW
    J Assoc Acad Minor Phys; 1992; 3(3):78-88. PubMed ID: 1353999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the treatment of peptic ulcer disease.
    Camara DS
    Compr Ther; 1987 Aug; 13(8):13-6. PubMed ID: 2887333
    [No Abstract]   [Full Text] [Related]  

  • 12. H2 receptor antagonists.
    Siepler JK; Campagna KD; Donahue PE; Bombeck CT
    Am J Hosp Pharm; 1978 Feb; 35(2):141-5. PubMed ID: 24338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acid anti-secretion therapy in gastric and duodenal ulcer].
    Lattanzi A
    Clin Ter; 1981 Oct; 99(2):187-205. PubMed ID: 6119184
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug therapy for peptic ulcer: drugs that act on the gastric mucosa.
    Kauffman GL
    J Clin Gastroenterol; 1981; 3(Suppl 2):95-101. PubMed ID: 6119340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Peptic ulcer: current therapy].
    Pieragnoli E
    G Clin Med; 1987 Apr; 68(4):197-209. PubMed ID: 2886387
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antagonists of the histamine H2 receptors in the stomach].
    Landa L
    Gac Med Mex; 1981 Dec; 117(12):472-4. PubMed ID: 6123460
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antacids and muscarinic and histamine H2 receptor blockaders in the treatment of peptic ulcer].
    Ivashkin VT; Minasian GA
    Klin Med (Mosk); 1987 Jan; 65(1):24-31. PubMed ID: 2882061
    [No Abstract]   [Full Text] [Related]  

  • 18. [Duodenal peptic ulcer. Medical therapy].
    Villalobos Pérez JJ
    Rev Gastroenterol Mex; 1984; 49(3):179-84. PubMed ID: 6151237
    [No Abstract]   [Full Text] [Related]  

  • 19. Potent versus mild acid suppression in peptic ulcer disease.
    Howden CW
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():45-6. PubMed ID: 1349552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of peptic ulcer with histamine H2 receptor antagonists].
    Domschke W; Domschke S; Demling L
    Fortschr Med; 1977 Aug; 95(31):1899-902. PubMed ID: 19347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.